Home » Clinical Trials » Phase II Study of a Novel Vitamin Metabolite (CoA-Z) for Pantothenate Kinase Associated Neurodegeneration
Phase II Study of a Novel Vitamin Metabolite (CoA-Z) for Pantothenate Kinase Associated Neurodegeneration

Research area:

Rare disease

Disease:

Pantothenate kinase associated neurodegeneration

Intervention:

Therapeutics – small molecules

Phase:

Phase II

Funding awarded to

University College London Great Ormond’s Street Hospital